For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
What Trump’s vaccine executive order actually does
Yesterday, President Trump signed an executive order directing federal health agencies to revise childhood vaccine recommendations, reducing the number of vaccines recommended for…
Blog
Trump administration decision highlights disastrous Part D redesign
The Trump administration recently announced the end of a demonstration project that was pulled together by the Biden administration as the Inflation Reduction…
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
Search Posts
Blog
Vioxx Class Action Rejected in New Jersey
The New Jersey Supreme Court just rejected a nationwide class action against Merck over its drug Vioxx, recognizing that it would be inappropriate to…
Newsletter
Issues in the News<?xml:namespace prefix = o ns = “urn:schemas-microsoft-com:office:office” /> 1. HEALTH AND SAFETY A recent…
Newsletter
CEI Daily Update
Issues in the News 1. ENVIRONMENT Consumers in the UK question the value of the billions of pounds paid every year in…
Blog
Alarming Waste
Today’s Washington Post includes a story on bisphenol A, a chemical that has been used to make flexible, clear plastic products–including baby bottles–since the…
Blog
FDA Tobacco Regulation Bill: A Trojan Horse?
PR Watch has an interesting story on the cynical baptist-bootlegger alliance behind the bill to give the FDA oversight over the tobacco industry, which…
Blog
Drug lag — precaution or pipelines?
According to a CNN Money article, a report released yesterday shows that the FDA has been cracking down on new drug approvals. Pharmaceutical companies…